![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA-Sponsored Report Recommends Reassessing All Opioids, Weighing Broader Impacts in Approvals
FDA-Sponsored Report Recommends Reassessing All Opioids, Weighing Broader Impacts in Approvals
![Some Pills](https://www.fdanews.com/ext/resources/test/pills1.jpg?t=1578614703&width=430)
July 19, 2017
An FDA-requested report from the National Academies of Sciences, Engineering and Medicine said it is possible to slow the spread of the opioid epidemic without limiting access to properly prescribed painkillers.
The report recommends actions for the FDA and other federal agencies, as well as state and local governments and healthcare-related organizations, but says the crisis will take years of coordinated efforts to reverse.
The report calls for more judicious prescribing of opioids, expanded access to treatments for opioid use disorder and addiction, investment in pain research to develop non-addictive alternatives and the assessment of societal impacts in regulatory decisions.
Upcoming Events
-
21Oct